Chronic renal denervation increases renal tubular response to P2X receptor agonists in rats: Implication for renal sympathetic nerve ablation

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3443-3448

  Kowalski, Robert ^a   Kreft, Ewelina ^a   Kasztan, Magorzata ^a   Jankowski, MacIej ^a,b   Szczepaska Konkel, Mirosawa ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

ablation; denervation; natriuresis; P2X receptors

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; PURINERGIC P2X RECEPTOR; PURINERGIC P2X RECEPTOR AGONIST; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SODIUM; SODIUM CHLORIDE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURESIS; ENZYME ACTIVITY; GLOMERULUS FILTRATION RATE; KIDNEY DENERVATION; KIDNEY INNERVATION; KIDNEY PROXIMAL TUBULE; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RAT; SHAM PROCEDURE; SODIUM URINE LEVEL; SYMPATHETIC INNERVATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARTERIAL PRESSURE; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; NOREPINEPHRINE; PYRIDOXAL PHOSPHATE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2X; SODIUM-POTASSIUM-EXCHANGING ATPASE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84865704768     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs087     Document Type: Article

References (31)

1. DiBona GF, Kopp U. Neural control of renal function. Physiol Rev 1997; 77: 75-197.
2. DiBona GF. Neural control of the kidney: functionally specific renal sympathetic nerve fibres. Am J Physiol 2000; 279: R1517-R1524.
3. Phillips JK. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents. Clin Exp Pharmacol Physiol 2005; 32: 415-418.
4. Schlaich MP, Socratous F, Hennebry S et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009; 20: 933-939.
5. Krum H, Schlaich M, Whitbourn R et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-1281.
6. Symplicity HTN-2 Investigators, Esler MD, Krum H et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903-1909.
7. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007; 87: 659-797.
8. Inscho EW. ATP, P2 receptors and the renal microcirculation. Purinergic Signal 2009; 5: 447-460.
9. Guan Z, Inscho EW. Role of adenosine 5'-triphosphate in regulating renal microvascular function and in hypertension. Hypertension 2011; 58: 333-340.
10. Praetorius HA, Leipziger J. Intrarenal purinergic signaling in the control of renal tubular transport. Annu Rev Physiol 2010; 72: 377-393.
11. Jankowski M, Szamocka E, Kowalski R et al. The effects of P2X receptor agonists on renal sodium and water excretion in anaesthetized rats. Acta Physiol (Oxf) 2011; 202: 193-201.
12. Burnstock B. Cotransmission. Curr Opin Pharmacol 2004; 4: 47-52.
13. Burnstock G, Krügel U, Abbracchio MP et al. Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol 2011; 95: 229-274.
14. Rohde GC, Huidobro-Toro JP. Purinergic supersensitivity following sympathectomy adds further support to co-transmission in the rat vas deferens. Arch Int Pharmacodyn Ther 1988; 294: 99-111.
15. Vinay P, Gougoux A, Lemieux G. Isolation of a pure suspension of rat proximal tubules. Am J Physiol 1981; 241: F403-F411.
16. Vinuela E, Salas M, Sols A. Glucokinase and hexokinase in liver in relation to glycogen synthesis. J Biol Chem 1963; 238: 1175-1177.
17. Fujita Y, Freese E. Purification and properties of fructose-1,6- bisphosphatase of Bacillus subtilis. J Biol Chem 1979; 254: 5340-5349.
18. Segura D, Eblen-Zajjur A, Proverbio F et al. A blood plasma inhibitor is responsible for circadian changes in rat renal Na, K-ATPase activity. Int J Biochem Cell Biol 2004; 36: 2054-2065.
19. Coddou C, Yan Z, Obsil T et al. Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev 2011; 63: 641-683.
20. von Kügelgen I, Wetter A. Molecular pharmacology of P2Yreceptors. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 310-323.
21. Jarvis MF, Khakh BS. ATP-gated P2X cation-channels. Neuropharmacology 2009; 56: 208-215.
22. Takeda M, Kobayashi M, Endou H. Establishment of a mouse clonal early proximal tubule cell line and outer medullary collecting duct cells expressing P2 purinoceptors. Biochem Mol Biol Int 1998; 44: 657-664.
23. Quan A, Baum M. Renal nerve stimulation augments effect of intraluminal angiotensin II on proximal tubule transport. Am J Physiol 2001; 282: F1043-F1048.
24. Franke H, Krügel U, Illes P. P2 receptors and neuronal injury. Pflugers Arch 2006; 452: 622-644.
25. Bailey MA, Turner CM, Hus-Citharel A et al. P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiol 2004; 96: 79-90.
26. Jin W, Hopfer U. Purinergic-mediated inhibition of Na+-K+-ATPase in proximal tubule cells: elevated cytosolic Ca2+ is not required. Am J Physiol 1997; 272: C1169-C1177.
27. Zhang YX, Yamashita H, Ohshita T et al. ATP induces release of newly synthesized dopamine in the rat striatum. Neurochem Int 1996; 28: 395-400.
28. Ciriello J, de Oliveira CV. Renal afferents and hypertension. Curr Hypertens Rep 2002; 4: 136-142.
29. Cao LH, Yang XL. Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol 2008; 84: 234-248.
30. Jankowski M. Purinergic regulation of glomerular microvasculature and tubular function. J Physiol Pharmacol 2008; 59(Suppl 9): 121-135.
31. Lazarowski ER, Sesma JI, Seminario-Vidal L et al. Molecular mechanisms of purine and pyrimidine nucleotide release. Adv Pharmacol 2011; 61: 221-261.